Xizang Weixinkang Pharmaceutical Co (SHSE:603676) E10: ¥0.35 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603676 Xizang Weixinkang Pharmaceutical Co Ltd SHSE:603676
75 GF Score
Price ¥8.78
GF Value ¥8.93
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Xizang Weixinkang Pharmaceutical Co E10?

Xizang Weixinkang Pharmaceutical Co SHSE:603676 +0.80% 75 E10 is ¥0.35 as of Mar. 2026. GuruFocus rates SHSE:603676 with a GF Score™ of 75/100 and a GF Value™ of ¥8.93 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Xizang Weixinkang Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was ¥0.160. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ¥0.35 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Xizang Weixinkang Pharmaceutical Co's average E10 Growth Rate was 6.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-30), Xizang Weixinkang Pharmaceutical Co's current stock price is ¥8.78. Xizang Weixinkang Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was ¥0.35. Xizang Weixinkang Pharmaceutical Co's Shiller PE Ratio of today is 25.09.

During the past 13 years, the highest Shiller PE Ratio of Xizang Weixinkang Pharmaceutical Co was 38.59. The lowest was 23.49. And the median was 32.68.


Xizang Weixinkang Pharmaceutical Co  (SHSE:603676) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Xizang Weixinkang Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=8.78/0.35
=25.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Xizang Weixinkang Pharmaceutical Co was 38.59. The lowest was 23.49. And the median was 32.68.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Xizang Weixinkang Pharmaceutical Co E10 Related Terms


Xizang Weixinkang Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Xizang Weixinkang Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xizang Weixinkang Pharmaceutical Co E10 Chart

Xizang Weixinkang Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.34

Xizang Weixinkang Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.33 0.34 0.34 0.34 0.35

SHSE:603676 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Xizang Weixinkang Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xizang Weixinkang Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Xizang Weixinkang Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Xizang Weixinkang Pharmaceutical Co's Shiller PE Ratio falls into.


SHSE:603676
75GF Score
Xizang Weixinkang Pharmaceutical Co Ltd SHSE:603676
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xizang Weixinkang Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Xizang Weixinkang Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.16/116.3033*116.3033
=0.160

Current CPI (Mar. 2026) = 116.3033.

Xizang Weixinkang Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.120 101.400 0.138
201609 0.040 102.400 0.045
201612 0.100 102.600 0.113
201703 0.060 103.200 0.068
201706 0.120 103.100 0.135
201709 0.030 104.100 0.034
201712 0.050 104.500 0.056
201803 0.080 105.300 0.088
201806 0.050 104.900 0.055
201809 0.020 106.600 0.022
201812 0.020 106.500 0.022
201903 0.048 107.700 0.052
201906 0.041 107.700 0.044
201909 0.020 109.800 0.021
201912 0.030 111.200 0.031
202003 0.030 112.300 0.031
202006 0.040 110.400 0.042
202009 0.040 111.700 0.042
202012 0.030 111.500 0.031
202103 0.040 112.662 0.041
202106 0.090 111.769 0.094
202109 0.060 112.215 0.062
202112 0.040 113.108 0.041
202203 0.090 114.335 0.092
202206 0.150 114.558 0.152
202209 0.110 115.339 0.111
202212 0.060 115.116 0.061
202303 0.140 115.116 0.141
202306 0.170 114.558 0.173
202309 0.180 115.339 0.182
202312 0.010 114.781 0.010
202403 0.220 115.227 0.222
202406 0.160 114.781 0.162
202409 0.180 115.785 0.181
202412 0.010 114.893 0.010
202503 0.200 115.116 0.202
202506 0.220 114.907 0.223
202509 0.090 115.471 0.091
202512 0.030 115.832 0.030
202603 0.160 116.303 0.160

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ¥0.35 mean?
Xizang Weixinkang Pharmaceutical Co (SHSE:603676) has a E10 of ¥0.35 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Xizang Weixinkang Pharmaceutical Co and its competitors.
Is Xizang Weixinkang Pharmaceutical Co's E10 too high?
Xizang Weixinkang Pharmaceutical Co's current E10 is ¥0.35. Overall, Xizang Weixinkang Pharmaceutical Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Xizang Weixinkang Pharmaceutical Co's E10 compare to ZTS?
Xizang Weixinkang Pharmaceutical Co's E10 of ¥0.35 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Xizang Weixinkang Pharmaceutical Co and its competitors. Xizang Weixinkang Pharmaceutical Co's current E10 is ¥0.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xizang Weixinkang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Xizang Weixinkang Pharmaceutical Co (SHSE:603676) is currently considered Fairly Valued. The stock's GF Value™ is ¥8.93, compared to a current price of ¥8.78 — trading 1.7% below its estimated fair value. The current E10 is ¥0.35. Xizang Weixinkang Pharmaceutical Co's overall GF Score™ is 75/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Xizang Weixinkang Pharmaceutical Co (SHSE:603676), the current E10 is ¥0.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xizang Weixinkang Pharmaceutical Co (SHSE:603676) Overvalued in 2026?

Based on GuruFocus' analysis, Xizang Weixinkang Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.78 is trading 1.7% below its estimated GF Value™ of ¥8.93. GuruFocus considers Xizang Weixinkang Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:603676:

  • E10: ¥0.35
  • GF Value™: ¥8.93 vs. price of ¥8.78 (1.7% below fair value)
  • GF Score™: 75/100 with 2 warning signs

No single metric tells the full story. See the SHSE:603676 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xizang Weixinkang Pharmaceutical Co Business Description

Address Yuanqu South Road, 3rd Floor, Building 4, Industrial Center, No. 5, Zone B, Lhasa Economic and Technological, Development Zone, Tibet Autonomous Region, Lhasa, CHN, 850000
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
75GF Score

Get the complete analysis for SHSE:603676

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.78
Price
¥8.93
GF Value